Immunology News and Research

Latest Immunology News and Research

Antimalarial drugs are also effective at treating a pulmonary disease, study finds

A research team at Colorado State University has discovered that drugs used to treat malaria are also effective at treating a pulmonary disease similar to tuberculosis.

21 Mar 2022

Oral drug that reverses immune aging effectively prevents death in COVID-19 mouse model

The immune system deteriorates with age, making COVID-19 particularly deadly in older people -; but to date, no clinically available medication addresses this key risk factor.

21 Mar 2022

IU researchers exploring new ways to treat seasonal or intermittent asthma

Researchers from Indiana University School of Medicine Department of Microbiology and Immunology are studying new ways to treat seasonal or intermittent asthma.

21 Mar 2022

New test greatly simplifies the diagnosis of allergies

Although allergies are widespread, their diagnosis is complex and, depending on the type of allergy, the prospects of success with therapy are not always clear.

21 Mar 2022

LJI study may open the door to new Parkinson's treatments and diagnostics

Scientists at La Jolla Institute for Immunology have found that people with Parkinson's disease have a clear "genetic signature" of the disease in their memory T cells.

21 Mar 2022

Pfizer CEO pushes yearly shots for covid. Not so fast, experts say.

When Pfizer CEO Albert Bourla said March 13 that all Americans would need a second booster shot, it struck many covid experts as a self-serving remark without scientific merit. It also set off spasms of doubt over the country's objectives in its fight against the coronavirus.

21 Mar 2022

Biological timeline of COVID-19 immune recovery described in new research

In a recent study published on the bioRxiv* preprint server, a group of researchers from the University of California, San Francisco, looked at intra-patient immunological changes over time to see if there were any changes in immune responses associated with successful COVID-19 resolution.

21 Mar 2022

Innate and adaptive immune responses to BNT162b2 vaccination in mice

Researchers analyzed the innate and adaptive responses to the mRNA-based BNT162b2 COVID-19 vaccine in mice.

18 Mar 2022

Two clever human antibodies can target Ebola and Sudan virus

Researchers at La Jolla Institute for Immunology (LJI) are designing better therapies for treating Ebola virus and its deadly relatives.

17 Mar 2022

Discovery of how NK cells are regulated in peripheral tissues could help combat cancer, other diseases

New research reveals factors that control the interplay of natural killer (NK) cells-; which are part of the body's innate, or first line, immune response-; with tumor cells, viral infections, and solid organ transplants.

16 Mar 2022

Toxin-producing yeast strains may damage the gut of patients with inflammatory bowel disease

Individual Candida albicans yeast strains in the human gut are as different from each other as the humans that carry them, and some C. albicans strains may damage the gut of patients with inflammatory bowel disease (IBD), according to a new study from researchers at Weill Cornell Medicine.

16 Mar 2022

New insight into how gut bacteria work to counter intestinal inflammation

Bile acids made by the liver have long been known for their critical role in helping to absorb the food we ingest.

16 Mar 2022

Epigenetic changes could be a biomarker for early detection of type 1 diabetes

Children who develop type 1 diabetes show epigenetic changes in the cells of their immune system already before the antibodies of the disease are detected in their blood.

16 Mar 2022

The Future of Tuberculosis; An Interview with the Bill & Melinda Gates Medical Research Institute

We speak to Dr. Alemnew Dagnew from the Bill & Melinda Gates Medical Research Institute, about their tuberculosis vaccine study and the future of tuberculosis.

16 Mar 2022

Researchers receive grant to find answers to taste loss in COVID patients

Up to 80% of individuals who've had COVID-19 report temporary or lasting changes in their sense of taste, and scientists are working to better understand the biological basis of why, including whether our taste buds are a direct virus target.

15 Mar 2022

Spray-on technology using customized gold nanoparticles could help treat heart disease

Could a spritz of super-tiny particles of gold and peptides on a damaged heart potentially provide minimally invasive, on-the-spot repair?

15 Mar 2022

Immune cells could help predict the prognosis of patients with ALS

Immune cells could help predict the prognosis of patients with the rare neurological disease amyotrophic lateral sclerosis (ALS), says a study published today in eLife.

15 Mar 2022

Researchers identify a potential new test for early diagnosis of Lyme disease

For scientists and clinicians alike, one of the Holy Grails for successfully treating and curing Lyme disease is developing tests that identify the disease sooner, show when people are cured of infection, and can diagnose reinfection.

15 Mar 2022

Study finds elevated inflammation in macrophages months after mild COVID-19

There is a lack of understanding as to why some people suffer from long-lasting symptoms after COVID-19 infection.

15 Mar 2022

Tumor cells’ 'ferroaddiction' can be exploited to deliver powerful anticancer drugs

Researchers at the University of California, San Francisco, have discovered that cells carrying the most common mutation found in human cancer accumulate large amounts of ferrous iron and that this "ferroaddiction" can be exploited to specifically deliver powerful anticancer drugs without harming normal, healthy cells.

11 Mar 2022

Immunology News and Research

Latest Immunology News and Research

Antimalarial drugs are also effective at treating a pulmonary disease, study finds

Oral drug that reverses immune aging effectively prevents death in COVID-19 mouse model

IU researchers exploring new ways to treat seasonal or intermittent asthma

New test greatly simplifies the diagnosis of allergies

LJI study may open the door to new Parkinson's treatments and diagnostics

Pfizer CEO pushes yearly shots for covid. Not so fast, experts say.

Biological timeline of COVID-19 immune recovery described in new research

Innate and adaptive immune responses to BNT162b2 vaccination in mice

Two clever human antibodies can target Ebola and Sudan virus

Discovery of how NK cells are regulated in peripheral tissues could help combat cancer, other diseases

Toxin-producing yeast strains may damage the gut of patients with inflammatory bowel disease

New insight into how gut bacteria work to counter intestinal inflammation

Epigenetic changes could be a biomarker for early detection of type 1 diabetes

The Future of Tuberculosis; An Interview with the Bill & Melinda Gates Medical Research Institute

Researchers receive grant to find answers to taste loss in COVID patients

Spray-on technology using customized gold nanoparticles could help treat heart disease

Immune cells could help predict the prognosis of patients with ALS

Researchers identify a potential new test for early diagnosis of Lyme disease

Study finds elevated inflammation in macrophages months after mild COVID-19

Tumor cells’ 'ferroaddiction' can be exploited to deliver powerful anticancer drugs

eBook: The Ultimate Guide to Successful Immunofluorescence eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production